These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8744632)

  • 1. Does activated protein C resistance increase the risk of systematic embolism in non rheumatic atrial fibrillation?
    Eikelboom J; Thom J; Van Bockxmeer F; Baker R
    Aust N Z J Med; 1996 Apr; 26(2):243-4. PubMed ID: 8744632
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of the G20210A mutation in the factor II gene with systemic embolism in nonvalvular atrial fibrillation.
    Pengo V; Filippi B; Biasiolo A; Pegoraro C; Noventa F; Iliceto S
    Am J Cardiol; 2002 Sep; 90(5):545-7. PubMed ID: 12208422
    [No Abstract]   [Full Text] [Related]  

  • 3. Strikes in French public transport and resistance to activated protein C.
    Eschwège V; Robert A
    Lancet; 1996 Jan; 347(8995):206. PubMed ID: 8544587
    [No Abstract]   [Full Text] [Related]  

  • 4. Preeclampsia is associated with a reduced response to activated protein C.
    Lindoff C; Ingemarsson I; Martinsson G; Segelmark M; Thysell H; Astedt B
    Am J Obstet Gynecol; 1997 Feb; 176(2):457-60. PubMed ID: 9065198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation. I. A study of atrial thrombosis and systemic embolism in a necropsy material.
    Aberg H
    Acta Med Scand; 1969 May; 185(5):373-9. PubMed ID: 5808636
    [No Abstract]   [Full Text] [Related]  

  • 6. Further evidence that activated protein C resistance affects protein C coagulant activity assays.
    Jennings I; Kitchen S; Cooper PC; Rimmer JE; Woods TA; Preston FE
    Thromb Haemost; 2000 Jan; 83(1):171-2. PubMed ID: 10669173
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosis of activated protein C resistance (factor V Leiden).
    Baker R; Thom J; van Bockxmeer F
    Lancet; 1994 Oct; 344(8930):1162. PubMed ID: 7934522
    [No Abstract]   [Full Text] [Related]  

  • 8. Central retinal vein thrombosis associated with resistance to activated protein C.
    Dhôte R; Bachmeyer C; Horellou MH; Toulon P; Christoforov B
    Am J Ophthalmol; 1995 Sep; 120(3):388-9. PubMed ID: 7661212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated protein C resistance and factor V Leiden in patients with hemolysis, elevated liver enzymes, low platelets syndrome.
    Krauss T; Augustin HG; Osmers R; Meden H; Unterhalt M; Kuhn W
    Obstet Gynecol; 1998 Sep; 92(3):457-60. PubMed ID: 9721789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Left atrial appendage in rheumatic mitral valve disease: The main source of embolism in atrial fibrillation].
    García-Villarreal OA; Heredia-Delgado JA
    Arch Cardiol Mex; 2017; 87(4):286-291. PubMed ID: 27986559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic tendency in 75 symptomatic, unrelated patients with APC resistance.
    Melichart M; Kyrle PA; Eichinger S; Rintelen C; Mannhalter C; Pabinger I
    Wien Klin Wochenschr; 1996; 108(19):607-10. PubMed ID: 8921576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemic stroke in the elderly. Role of the common factor V mutation causing resistance to activated protein C.
    Press RD; Liu XY; Beamer N; Coull BM
    Stroke; 1996 Jan; 27(1):44-8. PubMed ID: 8553401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical markers of embolic risk in patients with atrial fibrillation.
    Di Pasquale G; Urbinati S; Ribani MA; Passarelli P; Pinelli G
    G Ital Cardiol; 1994 Mar; 24(3):315-24. PubMed ID: 8063067
    [No Abstract]   [Full Text] [Related]  

  • 14. [Activated protein C resistance and mutation of coagulation factor V].
    Samama MM
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):669-70. PubMed ID: 8760650
    [No Abstract]   [Full Text] [Related]  

  • 15. Legg-Perthes disease in three siblings, two heterozygous and one homozygous for the factor V Leiden mutation.
    Gruppo R; Glueck CJ; Wall E; Roy D; Wang P
    J Pediatr; 1998 May; 132(5):885-8. PubMed ID: 9602208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four cases of venous thrombosis in athletes with silent hereditary defects of the protein C system.
    De Caterina M; Grimaldi E; Passaretti M; Ruocco A; Selvetella L; Cavallaro V; Di Biase S; Scopacasa F
    Thromb Haemost; 2005 Aug; 94(2):463-4. PubMed ID: 16113841
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cardiac rhythm and systemic embolism in long-term follow up of patients with non-valvular paroxysmal atrial fibrillation].
    Bugueño C; Corbalán R; Braun S; Tapia J; Kramer A; Huete I; Chávez A
    Rev Med Chil; 1998 Jun; 126(6):646-54. PubMed ID: 9778872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation.
    Vandenbroucke JP; Koster T; Briët E; Reitsma PH; Bertina RM; Rosendaal FR
    Lancet; 1994 Nov; 344(8935):1453-7. PubMed ID: 7968118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activated protein C resistance--an evaluation of current status].
    Hopmeier P
    Wien Klin Wochenschr; 1996; 108(19):599-606. PubMed ID: 9012145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activated protein C resistance in factor V disease: how high is the risk of thrombosis?].
    Spannagl M; Schramm W
    Dtsch Med Wochenschr; 1998 Feb; 123(6):137-9. PubMed ID: 9505951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.